Nature Biotechnology Podcast
Summary: Nature Biotechnology podcast is a series of conversations with founders, financers and developers from biotech's past, present and future.
- Visit Website
- RSS
- Artist: Nature Biotechnology
- Copyright: 20189 Springer Nature
Podcasts:
Anthony Davies discusses the past, present and future of stem cell therapies.
Julian Davies takes us through his long research career in Madison, Wisconsin; Paris and Geneva. He also discusses wrecking his motorcycle and how he met his wife.
Julian Davies takes us through his long research career in Madison, Wisconsin; Paris and Geneva. He also discusses wrecking his motorcycle and how he met his wife.
Leroy Hood talks through the founding of Applied Biosystems, the beginnings of the Human Genome Project and what drew him to mountain climbing.
Leroy Hood talks through the founding of Applied Biosystems, the beginnings of the Human Genome Project and what drew him to mountain climbing.
Nature Biotechnology talked to West about his initial love for physics, scoring the first funding for Geron and the future of regenerative medicine.
Nature Biotechnology talked to West about his initial love for physics, scoring the first funding for Geron and the future of regenerative medicine.
Nature Biotechnology spoke to Harvey Berger about developing Iclusig, the difference between managing a patient's health and running a company, and how a public entity deals with bad news.
Nature Biotechnology spoke to Berger about developing Iclusig, the difference between managing a patient's health and running a company, and how a public entity deals with bad news.
George Yancopoulos talks about the scientific foundation at Regeneron, upholding the family name and giving back through teaching.
George Yancopoulos talks about the scientific foundation at Regeneron, upholding the family name and giving back through teaching.
Una Ryan discusses the biotech East Coast vs. West; life in Oxford, UK; and her initial foray into industry via a job at Monsanto.
Una Ryan discusses the biotech East Coast vs. West; life in Oxford, UK; and her initial foray into industry via a job at Monsanto.
William A. Haseltine talks about his time at HGS, the future of genomics in drug discovery and how innovation might be funded going forward.
Nature Biotechnology spoke to William Haseltine about his time at HGS, the future of genomics in drug discovery and how innovation might be funded going forward.
